{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:08:53Z","timestamp":1781680133015,"version":"3.54.5"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"University of Ferrara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.nbd.2025.106881","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T17:59:12Z","timestamp":1742493552000},"page":"106881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice"],"prefix":"10.1016","volume":"208","author":[{"given":"Daniela","family":"Mercatelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Brugnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya R.","family":"Shimshek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Usiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Morari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.106881_bb0005","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1523\/JNEUROSCI.3905-08.2009","article-title":"Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function","volume":"29","author":"Abdallah","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0010","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3389\/fnins.2019.01352","article-title":"Autophagy and LRRK2 in the aging brain","volume":"13","author":"Albanese","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105487","article-title":"Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo","volume":"159","author":"Albanese","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106881_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-biochem-030122-051144","article-title":"Leucine-rich repeat kinases","volume":"93","author":"Alessi","year":"2024","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.nbd.2025.106881_bb0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0922-4106(90)90194-3","article-title":"Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy","volume":"188","author":"Andersen","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.106881_bb0030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bph.14123","article-title":"Anti-parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin\/orphanin FQ receptor agonists","volume":"175","author":"Arcuri","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.106881_bb0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0014-2999(92)90690-6","article-title":"Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro","volume":"213","author":"Arnt","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.106881_bb0040","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/hmg\/ddu543","article-title":"LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory","volume":"24","author":"Beccano-Kelly","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.106881_bb0045","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1471-4159.2011.07376.x","article-title":"Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels","volume":"118","author":"Bido","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106881_bb0050","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-2999(86)90449-8","article-title":"The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors","volume":"129","author":"Bischoff","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.106881_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1527-3458.2001.tb00207.x","article-title":"SCH 23390: the first selective dopamine D1-like receptor antagonist","volume":"7","author":"Bourne","year":"2001","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.nbd.2025.106881_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105044","article-title":"Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats","volume":"144","author":"Brugnoli","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106881_bb0065","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/cdd.2012.42","article-title":"(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD","volume":"19","author":"Chen","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2025.106881_bb0070","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58997","article-title":"Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutations","volume":"9","author":"Chen","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.nbd.2025.106881_bb0080","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0306-4522(99)00297-3","article-title":"Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase","volume":"93","author":"Clifford","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2025.106881_bb0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s002130050868","article-title":"Effects of D1 dopamine receptor agonists on oral ethanol self-administration in rats: comparison with their efficacy to produce grooming and hyperactivity","volume":"142","author":"Cohen","year":"1999","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.nbd.2025.106881_bb0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/acschemneuro.5b00020","article-title":"Identification of G protein-biased agonists that fail to recruit beta-arrestin or promote internalization of the D1 dopamine receptor","volume":"6","author":"Conroy","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.parkreldis.2009.11.004","article-title":"Worldwide frequency of G2019S LRRK2 mutation in Parkinson\u2019s disease: a systematic review","volume":"16","author":"Correia Guedes","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.106881_bb0100","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41386-023-01731-z","article-title":"Leucine-rich repeat kinase 2 limits dopamine D1 receptor signaling in striatum and biases against heavy persistent alcohol drinking","volume":"49","author":"da Silva","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2025.106881_bb0105","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1111\/j.1476-5381.1995.tb16420.x","article-title":"Pharmacological characterization of behavioural responses to SK&F 83959 in relation to \u2018D1-like\u2019 dopamine receptors not linked to adenylyl cyclase","volume":"116","author":"Deveney","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.106881_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040881","article-title":"Dopamine transporter, PhosphoSerine129 alpha-Synuclein and alpha-Synuclein levels in aged LRRK2 G2019S Knock-in and Knock-out mice","volume":"10","author":"Domenicale","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.nbd.2025.106881_bb0115","doi-asserted-by":"crossref","DOI":"10.1042\/NS20220040","article-title":"Modeling Parkinson's disease in LRRK2 rodents","volume":"7","author":"Domenicale","year":"2023","journal-title":"Neuronal Signal."},{"key":"10.1016\/j.nbd.2025.106881_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/exnr.1999.7037","article-title":"Paradoxical locomotor behavior of dopamine D1 receptor transgenic mice","volume":"157","author":"Dracheva","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106881_bb0125","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3233\/JPD-202138","article-title":"LRRK2 and the Endolysosomal system in Parkinson\u2019s disease","volume":"10","author":"Erb","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2025.106881_bb0130","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1471-4159.2007.04966.x","article-title":"NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways","volume":"103","author":"Fantin","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106881_bb0135","article-title":"Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: an historical perspective","volume":"14","author":"Gerfen","year":"2022","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0140","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.106881_bb0145","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1523\/JNEUROSCI.3952-07.2008","article-title":"Differences between dorsal and ventral striatum in Drd1a dopamine receptor coupling of dopamine- and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinase","volume":"28","author":"Gerfen","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","article-title":"Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin","volume":"23","author":"Greggio","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106881_bb0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1471-4159.2007.04523.x","article-title":"Mutations in LRRK2\/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1","volume":"102","author":"Greggio","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106881_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/BST20160396","article-title":"Cross-talk between LRRK2 and PKA: implication for Parkinson\u2019s disease?","volume":"45","author":"Greggio","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2025.106881_bb0165","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1152\/jn.00137.2020","article-title":"LRRK2 mutation alters behavioral, synaptic, and nonsynaptic adaptations to acute social stress","volume":"123","author":"Guevara","year":"2020","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2025.106881_bb0170","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.106881_bb0175","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1523\/JNEUROSCI.15-07-05222.1995","article-title":"Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents","volume":"15","author":"Hersch","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0180","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1093\/hmg\/ddr348","article-title":"LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice","volume":"20","author":"Herzig","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.106881_bb0185","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1037\/0735-7044.115.5.1129","article-title":"Behavioral characterization of dopamine D5 receptor null mutant mice","volume":"115","author":"Holmes","year":"2001","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(83)90381-3","article-title":"SCH 23390 - the first selective dopamine D-1 antagonist","volume":"91","author":"Hyttel","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.106881_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-022-02437-0","article-title":"Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease","volume":"144","author":"Iovino","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.106881_bb0200","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1042\/BCJ20160557","article-title":"Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors","volume":"473","author":"Ito","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2025.106881_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113107","article-title":"Biphasic patterns of age-related differences in dopamine D1 receptors across the adult lifespan","volume":"42","author":"Johansson","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.106881_bb0210","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","article-title":"Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease","volume":"72","author":"Kalia","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2025.106881_bb0215","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1523\/JNEUROSCI.15-07-05379.1995","article-title":"D1 receptors modulate glutamate transmission in the ventral tegmental area","volume":"15","author":"Kalivas","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neurobiolaging.2017.05.006","article-title":"Reduced dopamine receptors and transporters but not synthesis capacity in normal aging adults: a meta-analysis","volume":"57","author":"Karrer","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.106881_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BCJ20170802","article-title":"Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson\u2019s disease kinase","volume":"475","author":"Lis","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2025.106881_bb0230","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2014.07.013","article-title":"Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging","volume":"71","author":"Longo","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106881_bb0235","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-017-0426-8","article-title":"Age-dependent dopamine transporter dysfunction and Serine129 phospho-alpha-synuclein overload in G2019S LRRK2 mice","volume":"5","author":"Longo","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2025.106881_bb0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuroscience.2009.12.006","article-title":"Endogenous nociceptin\/orphanin FQ (N\/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naive and nociceptin\/orphanin FQ receptor knockout mice","volume":"166","author":"Mabrouk","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2025.106881_bb0245","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1471-4159.2002.01169.x","article-title":"Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors","volume":"83","author":"Marti","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106881_bb0250","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1523\/JNEUROSCI.0987-04.2004","article-title":"Blockade of nociceptin\/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior","volume":"24","author":"Marti","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0255","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1471-4159.2005.03015.x","article-title":"Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine","volume":"93","author":"Marti","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106881_bb0260","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1523\/JNEUROSCI.2546-05.2005","article-title":"Blockade of nociceptin\/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson\u2019s disease","volume":"25","author":"Marti","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0265","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1523\/JNEUROSCI.4346-06.2007","article-title":"The nociceptin\/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway","volume":"27","author":"Marti","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0270","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.beproc.2005.09.008","article-title":"Dopamine D1 activation shortens the duration of phases in stereotyped grooming sequences","volume":"71","author":"Matell","year":"2006","journal-title":"Behav. Process."},{"key":"10.1016\/j.nbd.2025.106881_bb0275","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1523\/JNEUROSCI.3314-15.2016","article-title":"Altered development of synapse structure and function in striatum caused by Parkinson\u2019s disease-linked LRRK2-G2019S mutation","volume":"36","author":"Matikainen-Ankney","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.484","article-title":"Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes","volume":"7","author":"Mercatelli","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.nbd.2025.106881_bb0285","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/mds.27272","article-title":"Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson\u2019s disease nonparkinsonian relatives: a multicenter family study","volume":"33","author":"Mestre","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106881_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077198","article-title":"LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization","volume":"8","author":"Migheli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.106881_bb0295","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF00427697","article-title":"Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390","volume":"82","author":"Molloy","year":"1984","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.nbd.2025.106881_bb0300","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0306-4522(95)00557-9","article-title":"Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--I. Effects of perfusion with tetrodotoxin and low-calcium medium","volume":"72","author":"Morari","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2025.106881_bb0305","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-0186(98)00052-7","article-title":"Reciprocal dopamine-glutamate modulation of release in the basal ganglia","volume":"33","author":"Morari","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2025.106881_bb0310","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/mds.26326","article-title":"Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity","volume":"30","author":"Paolone","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106881_bb0315","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nn.3636","article-title":"LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity","volume":"17","author":"Parisiadou","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.106881_bb0320","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.nbd.2025.106881_bb0325","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/bph.15730","article-title":"Regulator of G-protein Signalling 4 (RGS4) negatively modulates nociceptin\/orphanin FQ opioid receptor signalling: implication for l-Dopa-induced dyskinesia","volume":"180","author":"Pisano","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.106881_bb0330","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jnc.15240","article-title":"LRRK2 at the pre-synaptic site: a 16-years perspective","volume":"157","author":"Pischedda","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106881_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018568","article-title":"Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2","volume":"6","author":"Ramonet","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.106881_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179082","article-title":"Role of LRRK2 in the regulation of dopamine receptor trafficking","volume":"12","author":"Rassu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.106881_bb0345","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.nbd.2018.11.012","article-title":"The role of monogenic genes in idiopathic Parkinson\u2019s disease","volume":"124","author":"Reed","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106881_bb0350","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/bjp.2008.96","article-title":"Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice","volume":"154","author":"Rizzi","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.106881_bb0355","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0306-4522(97)00160-7","article-title":"Reciprocal interaction between glutamate and dopamine in the pars reticulata of the rat substantia nigra: a microdialysis study","volume":"80","author":"Rosales","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2025.106881_bb0360","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1385-299X(97)00034-2","article-title":"An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism","volume":"2","author":"Rozas","year":"1997","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.nbd.2025.106881_bb0365","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12974-015-0449-7","article-title":"Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-kappaB p50 signaling in cultured microglia cells","volume":"12","author":"Russo","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2025.106881_bb0370","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamaneurol.2017.4019","article-title":"Progression in the LRRK2-Asssociated Parkinson disease population","volume":"75","author":"Saunders-Pullman","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2025.106881_bb0375","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0165-6147(94)90323-9","article-title":"Dopamine receptor pharmacology","volume":"15","author":"Seeman","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2025.106881_bb0380","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mds.27989","article-title":"Clinical and dopamine transporter imaging characteristics of leucine rich repeat kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson\u2019s disease participants in the Parkinson\u2019s progression markers initiative: a cross-sectional study","volume":"35","author":"Simuni","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.106881_bb0385","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0028-3908(86)90168-1","article-title":"Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors","volume":"25","author":"Starr","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2025.106881_bb0390","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0091-3057(86)90421-1","article-title":"Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390","volume":"24","author":"Starr","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2025.106881_bb0395","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1073\/pnas.0906334106","article-title":"R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice","volume":"106","author":"Tong","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106881_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2018.06.008","article-title":"Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson\u2019s disease","volume":"118","author":"Tozzi","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106881_bb0405","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41419-017-0221-2","article-title":"Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease","volume":"9","author":"Tozzi","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2025.106881_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(88)90141-0","article-title":"Increased grooming behaviour is induced by apomorphine in mice treated with discriminant benzamide derivatives","volume":"156","author":"Vasse","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.106881_bb0415","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.nbd.2008.02.011","article-title":"Nociceptin\/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism","volume":"30","author":"Viaro","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106881_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147583","article-title":"L-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter","volume":"1768","author":"Viaro","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2025.106881_bb0425","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.parkreldis.2015.07.025","article-title":"Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release","volume":"21","author":"Volta","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2025.106881_bb0430","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.28377","article-title":"Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice","volume":"6","author":"Volta","year":"2017","journal-title":"Elife"},{"issue":"Pt 1","key":"10.1016\/j.nbd.2025.106881_bb0435","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.expneurol.2015.09.001","article-title":"(R1441C) LRRK2 induces the degeneration of SN dopaminergic neurons and alters the expression of genes regulating neuronal survival in a transgenic mouse model","volume":"275","author":"Weng","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106881_bb0440","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106881_bb0445","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1471-4159.2006.03901.x","article-title":"Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors","volume":"98","author":"Wu","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106881_bb0450","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s42003-022-04136-8","article-title":"R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations","volume":"5","author":"Xenias","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.nbd.2025.106881_bb0455","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-3-319-49969-7_9","article-title":"Models of LRRK2-associated Parkinson\u2019s disease","volume":"14","author":"Xiong","year":"2017","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.nbd.2025.106881_bb0460","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1073\/pnas.1712648115","article-title":"Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice","volume":"115","author":"Xiong","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.106881_bb0465","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nbd.2010.04.002","article-title":"LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson\u2019s disease","volume":"40","author":"Yao","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106881_bb0075","article-title":"LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons","author":"Chen","year":"2024","journal-title":"bioRxiv"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612500097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612500097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T13:13:31Z","timestamp":1762348411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999612500097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":93,"alternative-id":["S096999612500097X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106881","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106881"}}